Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Market Cap : 124.52B for Feb. 25, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 206.55B |
| Gilead Sciences, Inc. | 183.29B |
| Regeneron Pharmaceuticals, Inc. | 82.62B |
| Janux Therapeutics, Inc. | 822.22M |
| Moderna, Inc. | 20.22B |
Market Cap Related Metrics
| PE Ratio | 17.68 |
| PS Ratio | 2.588 |
| Price to Book Value | 6.741 |
| Price to Free Cash Flow | 9.708 |
| Price | 61.14 |
| Earnings Yield | 5.66% |
| Operating PE Ratio | 8.250 |
| Normalized PE Ratio | 10.61 |